Sales decline 42.74% to Rs 40.52 crore
Net loss of Valiant Laboratories reported to Rs 3.50 crore in the quarter ended December 2023 as against net profit of Rs 7.65 crore during the previous quarter ended December 2022. Sales declined 42.74% to Rs 40.52 crore in the quarter ended December 2023 as against Rs 70.77 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales40.5270.77 -43 OPM %-15.6014.03 -PBDT-4.5610.67 PL PBT-5.0510.27 PL NP-3.507.65 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
